Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2013; 19(13): 2097-2103
Published online Apr 7, 2013. doi: 10.3748/wjg.v19.i13.2097
Figure 1
Figure 1 Patients with complete response. A, B: Abdominal computed tomography (CT) in patients with gastric cancer with multiple synchronous liver metastases (GCLM) after preoperative chemotherapy; C, D: Abdominal CT in patients with GCLM after neoadjuvant chemotherapy.
Figure 2
Figure 2 Patients with partial response. A: Abdominal computed tomography (CT) in gastric cancer with multiple synchronous liver metastases (GCLM) patient treated with preoperative chemotherapy (June 3, 2011); B: Abdominal CT in patient with GCLM after neoadjuvant chemotherapy (August 29, 2011); C: Abdominal CT in patient with GCLM after neoadjuvant chemotherapy (November 8, 2011); D: Abdominal CT in patient with GCLM after neoadjuvant chemotherapy (February 2, 2012).
Figure 3
Figure 3 Overall survival of patients with hepatic metastases from gastric cancer.